Cenix BioScience has signed a research agreement with SYGNIS Bioscience to advance the SYGNIS KIBRA project aimed at developing treatments for various forms of dementia. Cenix will apply its expertise in combining high content screening with gene silencing analyses in cultured human cells, to establish and optimize multi-parametric microscopy-based assays using the Definiens XD image analysis system. Using these assays, Cenix will conduct target validation to prioritize novel therapeutic drug t...